Mode
Text Size
Log in / Sign up

Vision-language foundation models show inconsistent reporting of clinical metrics and limited interpretability in medical imagingAudit Reveals Reporting Gaps in Medical Image AI Models

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that VLFMs for medical imaging currently lack standardized reporting of critical performance and clinical metrics.

This narrative review with quantitative synthesis examines the current state of vision-language foundation models (VLFMs) specifically for medical image understanding. The authors synthesized data from 50 original studies and conducted an audit of 13 representative studies to evaluate the reporting of key performance indicators and technical metrics.

The audit revealed significant inconsistencies in reporting. Specifically, 31% (4/13) of studies reported BLEU/ROUGE scores and human expert evaluations, while 46% (6/13) reported CheXpert- or CheXbert-derived label evaluations. Conversely, 0% (0/13) of the audited studies reported RadGraph F1 scores or inference latency and throughput. Only 8% (1/13) reported BERTScore. These findings suggest that the current literature lacks a standardized framework for evaluating VLFMs in clinical contexts.

Several limitations are noted, including the risk of hallucination, limited interpretability, distribution shift, and narrow demographic and geographic coverage. The authors emphasize that cross-task results should be viewed as exploratory benchmark indicators rather than a scale for clinical readiness. Clinical adoption should be guided by source-traceable, clinically grounded, and externally validated evidence to ensure safety and reliability in medical imaging applications.

Researchers conducted a narrative review and audit of vision-language foundation models (VLFMs) used for understanding medical images. They looked at 50 original studies and performed a detailed audit of 13 representative studies to see how well these AI models were being reported in scientific literature.

The audit found that many important metrics were missing from the reports. For example, only 31% of the audited studies reported human expert evaluations, and only 46% reported specific label evaluations. Other metrics, such as RadGraph F1 scores and inference speed, were not reported in any of the 13 audited studies.

Because these reports are often incomplete, it is difficult to know exactly how these models perform in real-world medical settings. The study notes that these models may also face issues like hallucination and limited interpretability. While these AI tools are promising, experts suggest that progress should only be judged by evidence that is traceable, clinically grounded, and validated by outside experts.

What this means for you:
Current research on medical AI models often lacks the consistent reporting needed to fully judge their clinical readiness.

Common questions

What did the study find about how these AI models are reported?

The audit of 13 studies found that many important metrics were missing. For example, only 31% of the studies reported human expert evaluations, and 46% reported label evaluations. Other metrics, like inference latency or RadGraph F1 scores, were not reported in any of the 13 audited studies.

Are these AI models ready for clinical use?

The study does not say if they are ready. It notes that while these models are promising, they face issues like hallucination and limited interpretability. Progress should be judged by evidence that is clinically grounded and externally validated before they can be used in medical practice.

Study Details

Study typeMeta analysis
EvidenceLevel 1
PublishedOct 2026
View Original Abstract ↓
Vision-language foundation models (VLFMs) for medical image understanding have advanced rapidly, yet evidence supporting clinical deployment remains fragmented. This narrative review synthesizes architectures, training paradigms, benchmarks, public datasets, and translation barriers. Drawing on more than 50 original studies published between 2020 and 2025, we provide a structured descriptive comparison rather than a statistical meta-analysis. In a focused audit of 13 representative studies, BLEU/ROUGE was reported by 31% (4/13), RadGraph F1 by 0% (0/13), CheXpert- or CheXbert-derived label evaluation by 46% (6/13), BERTScore by 8% (1/13), human expert evaluation by 31% (4/13), and inference latency or throughput by 0% (0/13). Because datasets, splits, candidate pools, and metrics differ, cross-task results are presented as exploratory benchmark indicators and not as a clinical-readiness scale. The synthesis identifies persistent concerns involving hallucination, limited interpretability, distribution shift, and narrow demographic and geographic coverage. We propose a minimum clinical validation and reporting standard aligned with the distinct purposes of FDA/Health Canada/MHRA and IMDRF Good Machine Learning Practice, the EU AI Act, TRIPOD+AI, and CLAIM, and identify eleven priority research directions. Medical VLFMs are promising, but progress should be judged by source-traceable, clinically grounded, and externally validated evidence.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.